Friday, 23 January 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 23 January 2026
News

Four new treatments hit TGA

Posted 20 January 2026 AM

Four new drugs are on their way to Australia, with another expanding its indicated population and a sixth becoming a new use for an old drug.

Newly-minted Pharming Australia is seeking a second indication for its first drug, Joenja. The drug received a PBAC recommendation in July for the treatment of symptomatic activated phosphoinositide 3-kinase delta syndrome (APDS) in adults and adolescents aged 12 years and older, for which it had previously received priority review and orphan drug designation.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (13)

Access & Reimbursement (1)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (5)

Other (12)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.